Summary of this article
Anlon Healthcare Ltd shares made a flat debut on the NSE and BSE on September 3.
Retail investors who were allotted at least one lot or 164 shares of Anlon Healthcare Ltd would have made a minimum profit of Rs 164.
Anlon Healthcare Ltd seeks to use the money raised via the public issue for funding capital expenditure requirements, repayment or prepayment of outstanding secured borrowings.
Anlon Healthcare Ltd shares made a flat debut on the NSE and BSE on September 3 with muted gains. Anlon Healthcare shares listed on the NSE at Rs 92 apiece, up by 1.09 per cent compared to the upper end of the public issue’s price band of Rs 91 apiece. The stock soon gained 1.64 per cent to trade at an early high of Rs 92.5 apiece. On the other hand Anlon Healthcare Ltd shares made their debut on the BSE at Rs 91 apiece with no gains.
Retail investors who were allotted at least one lot or 164 shares of Anlon Healthcare Ltd would have made a minimum profit of Rs 164 (Rs 92 - Rs 91 x 164) after the stock started trading on the exchange. After the stock began to trade, 21.83 lakh shares of the company changed hands on the NSE. The company's total market capitalisation stood at Rs 488.94 crore.
Anlon Healthcare IPO: Details
Anlon Healthcare IPO was worth Rs 121.03 crore. The book-built issue consisted of a fresh issuance of 13.3 million shares. Anlon Healthcare IPO price band was set between Rs 86 to Rs 91 per share.
The minimum lot size for application for retail investors was fixed at 1 lot or 164 shares, which aggregated to an investment of Rs 14,924. Anlon Healthcare IPO was booked 7 times during the three-day bidding window which opened on August 26 and closed on August 29. Cumulatively, Anlon Healthcare IPO received bids for over 94.7 million shares compared to the 13.3 million shares offered for subscription.
The non-institutional investors (NII) booked their portion in Anlon Healthcare IPO 10.61 times. The Anlon Healthcare IPO was booked 47.3 times in the retail individual investor category. The mainboard issue was booked 1.07 times in the Qualified Institutional Buyers (QIB) category.
Anlon Healthcare Ltd seeks to use the money raised via the public issue for funding capital expenditure requirements, repayment or prepayment of outstanding secured borrowings, funding the working capital requirements and general corporate purposes.
Anlon Healthcare Ltd is a manufacturer of specialty chemicals which are used in the pharmaceutical industry. The products made by Anlon Healthcare are used for making pharma intermediates and active pharmaceutical ingredients (APIs). The company also makes high-purity pharmaceutical intermediates (for API production) and active pharmaceutical ingredients.
At the time of writing shares of Anlon Healthcare shares traded at Rs 91.28 apiece up by 1 per cent on the NSE.
